|View printer-friendly version|
|BrainStorm Granted GMP Certification for a Marketing-Level Manufacturing of NurOwn®|
"BrainStorm received overwhelming demand from patients and physicians in many countries for access to NurOwn®. We are pleased to receive this important GMP approval, taking us one step closer to making our therapy available to patients who do not have the opportunity to participate in our U.S. trial," said Dr.
"ALS is a debilitating neurodegenerative disease with few treatment options available," said
View original content with multimedia:http://www.prnewswire.com/news-releases/brainstorm-granted-gmp-certification-for-a-marketing-level-manufacturing-of-nurown-300576968.html